Moscow has suggested to Tokyo that a green corridor be created for pharmaceutical companies, Russian Deputy Prime Minister Olga Golodets said ahead of a meeting with Japan’s Minister of Economy, Trade and Industry Hiroshige Seko on Saturday.
“We have suggested that the so-called green corridor be created for pharmaceutical companies, as we want to ease the access to the Russian market for Japanese companies,” she said, adding that talks on that matter have been held with Hitachi, Ltd.
The meeting also involves Russian Economic Development Minister Maksim Oreshkin.
Moscow and Tokyo have been have been boosting economic cooperation based on the Japanese prime minister’s eight-point plan. The document stipulates that Russia and Japan should strengthen relations in the energy sphere, small and medium-size business, the industrialization of Russia’s Far East, as well as expand exports.
Source: TASS
Giovanni Caforio, the former CEO of Bristol Myers Squibb, is set to become the next board chairman of Novartis, which on Tuesday proposed the pharmaceutical industry veteran as its pick to replace Joerg Reinhardt in the role next year. Reinhardt has served as Novartis’ chair since 2013 and plans to retire when his 12-year term ends in 2025.
GE HealthCare has raised the curtain on two ultrasound systems equipped with artificial intelligence programs designed to assist in diagnosing conditions in women’s health, including obstetric exams. The Voluson Signature 20 and 18 imaging systems include AI tools capable of automatically identifying and annotating measurements of fetal anatomy.
Scientists from the University of Edinburgh’s School of Chemistry have revealed a new sustainable method of manufacturing complex molecules that could reduce waste produced during drug production. The method published in Nature Chemistry could help to prevent severe side effects caused by drugs that can exist as enantiomers.
